Description
What it is
Triple agonist (GLP-1, GIP, glucagon receptors). Investigational for body composition and metabolic remodeling.
Mechanism
Retatrutide simultaneously activates GLP-1, GIP and glucagon receptors. Proposed to drive both energy expenditure and appetite regulation.
Specifications
- Peptide content: 20mg / vial
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
For laboratory research only. Not for human or veterinary use.
